Search Results
Aug 07, 2025, 11:07 ET Smilegate veröffentlicht das AAA-Open-World-Spiel von Absurd Ventures, das im Universum von A BETTER PARADISE spielt
bekannt gegeben, einen Vertrag mit Absurd Ventures von Dan Houser unterzeichnet zu haben, um das kommende AAA, Open-World, Sci-Fi-Action-Adventure-Spiel des Studios zu veröffentlichen, das in dem faszinierenden Universum von A BETTER PARADISE spielt. Die Partnerschaft folgt auf
More news about: Smilegate
Aug 07, 2025, 08:40 ET Sebela Pharmaceuticals® Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results
Izat E. Patient and physician satisfaction with proton pump inhibitors (PPIs): are there opportunities for improvement? Dig Dis Sci. 2010
More news about: Sebela Pharmaceuticals
Aug 07, 2025, 06:25 ET Lilly's oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity
Kobilka, & K.W. Sloop, Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist, Proc. Natl. Acad. Sci. U.S.A. 117 (47) 29959-29967,
More news about: Eli Lilly and Company
Aug 06, 2025, 12:12 ET SERVICE CORPORATION INTERNATIONAL DECLARES QUARTERLY CASH DIVIDEND
HOUSTON, Aug. 6, 2025 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today announced that its Board of Directors
More news about: Service Corporation International
Aug 06, 2025, 09:00 ET Smilegate to Publish Absurd Ventures' AAA Open-World Game Set in the A BETTER PARADISE Universe
has signed an agreement with Dan Houser's Absurd Ventures to globally publish the studio's upcoming AAA, open-world, sci-fi action-adventure game, set in its mind-bending A BETTER PARADISE universe. The partnership follows Smilegate's strategic investment in Absurd Ventures,
More news about: Smilegate
Aug 06, 2025, 09:00 ET Smilegate to Publish Absurd Ventures' AAA Open-World Game Set in the A BETTER PARADISE Universe
has signed an agreement with Dan Houser's Absurd Ventures to globally publish the studio's upcoming AAA, open-world, sci-fi action-adventure game, set in its mind-bending A BETTER PARADISE universe. The partnership follows Smilegate's strategic investment in Absurd Ventures,
More news about: Smilegate
Aug 05, 2025, 05:14 ET World Intelligent Vehicle Conference 2025 Successfully Concludes
Innovation Competition, Business Investigation of Chongqing Intelligent Vehicle Ecosystem, Experience of Chongqing Intelligent Driving, and Exhibition of Sci-Tech Innovation Achievements in Intelligent Vehicle. From brainstorming and strategy discussion to achievement exhibition, followed by resource matchmaking
More news about: Asia Digital Group
Aug 01, 2025, 13:36 ET BOAT ROCKER STUDIOS COMPLETES MANAGEMENT BUYOUT, BEGINS NEXT CHAPTER AS INDEPENDENT PRIVATE COMPANY
Brooke Shields (Hulu), Downey's Dream Cars (Max), BS High (HBO), Orphan Black (BBC AMERICA, CTV Sci-Fi Channel), Billie Eilish: The World's a Little Blurry (Apple TV+), The Next Step (BBC, Corus, CBC), Daniel Spellbound (Netflix),
More news about: Boat Rocker Studios
Jul 31, 2025, 10:18 ET FROM FICTION TO FORTUNE: HOLLYWOOD'S MOST LEGENDARY PROPS STAR IN $10 MILLION AUCTION SPECTACLE
PUBLIC AUCTION, WITH A PRE-SALE ESTIMATE OF $250,000 – $500,000. - A STANDOUT SCI-FI PROP - THE LIGHT-UP CLOSE-UP NEURALYZER FROM MEN IN BLACK (1997), USED BY AGENTS J (WILL SMITH) AND K (
More news about: Propstore
Jul 30, 2025, 16:15 ET SERVICE CORPORATION INTERNATIONAL ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS, CONFIRMS 2025 EARNINGS PER SHARE GUIDANCE AND RAISES 2025 CASH FLOW GUIDANCE
HOUSTON, July 30, 2025 /PRNewswire/ -- Service Corporation International (NYSE: SCI), the largest provider of deathcare products and services in North America, today reported results for the second quarter
More news about: Service Corporation International
Jul 30, 2025, 11:00 ET Two-Year Real-World Study of LEQEMBI® in the United States Presented at Alzheimer's Association International Conference (AAIC) 2025
Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 09:00 ET New Data Presented at AAIC Demonstrates Investigational LEQEMBI® (lecanemab-irmb) 360 mg Subcutaneous Maintenance Dosing Could Offer a New Option for Ongoing Treatment of Early Alzheimer's Disease
doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 08:07 ET Early Alzheimer's Patients Continue to Benefit from Four Years of LEQEMBI® (lecanemab-irmb) Therapy New Clinical Data Presented at AAIC
doi:10.1038/s41467-021-23507-zOno K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.
More news about: Eisai Inc.
Jul 30, 2025, 04:22 ET The Future is Here: Embodied Intelligent Robots
Sci-tech innovation is the core element for developing new quality productive forces. In China today, such productive forces are undergoing robust development, as evidenced by a constant stream of sci-tech innovation achievements.
More news about: en.qstheory.cn
Jul 29, 2025, 10:30 ET AWARD-WINNING GEM® PREMIER™ 7000 with iQM®3 EXPANDS COMMERCIALIZATION TO EUROPE
doi:10.1515/CCLM.2009.132.Lippi G, Plebani M, Di Somma S, Cervellin G. Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci. 2011;48(3):143–153. doi:10.3109/10408363.2011.600228.O'Hara M, Wheatley EG, Kazmierczak SC. The impact of undetected in vitro hemolysis
More news about: Werfen
Jul 29, 2025, 04:00 ET DealMakerInsider.com Publishes a New White Paper for M&A Advisors on Reframing Sell-Side Qualification in Tech
in future liabilities for you and your brokerage." Art Howarth holds a Bachelor of Computer Science (B. Comp Sci), from the faculty of Engineering & Computer Science at Concordia University. In this article, he shares expert insights on how to improve the qualification
More news about: M&A Source
Jul 28, 2025, 09:10 ET XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury
first "off-the-shelf", allogeneic, iPSC-derived, spinal neural progenitor cell therapy targeting major neurological disorders, specifically spinal cord injury (SCI) – has commenced. The clinical trial initiation meeting was held at The Third Affiliated Hospital of Sun Yat-sen University
More news about: XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd.
Jul 25, 2025, 03:42 ET Humanoid Robot Industry Chain Matchmaking Event Held at 3rd CISCE
of China Council for the Promotion of International Trade (CCPIT), highlighted Hubei's strategic location, rich sci-tech resources, innovation ecosystem, and openness. He noted the province's rapid progress in humanoid robotics, spanning smart manufacturing, core component
More news about: China International Supply Chain Expo
Jul 25, 2025, 03:18 ET Humanoid Robot Industry Chain Matchmaking Event Held at 3rd CISCE
of China Council for the Promotion of International Trade (CCPIT), highlighted Hubei's strategic location, rich sci-tech resources, innovation ecosystem, and openness. He noted the province's rapid progress in humanoid robotics, spanning smart manufacturing, core component
More news about: China International Supply Chain Expo
Jul 23, 2025, 06:50 ET BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
).ii Woodley, W. D. et al. Clinical Evaluation of an Investigational 5ml Wearable Injector in Healthy Human Subjects. Clin Transl Sci. 2021 May;14(3):859-869. doi.org/10.1111/cts.12946.iii Pharma filled and assemblediv Mordor Intelligence (2025).
More news about: BD (Becton, Dickinson and Company)
Jul 22, 2025, 13:48 ET Newly Published Research Shows Groundbreaking Joint Treatment Changes the Course of Dog Arthritis Management
al. Evidence of osteoarthritis disease modification with a Sn-117m microparticle device: a review and validation in mammalian models. Front. Vet. Sci. 2-25;12:1-13 doi: 10.3389/fvets.2025.1621296.Aulakh KS, Lopez MJ, Hudson C, et al. Prospective Clinical Evaluation of Intra-Articular Injection
More news about: Synovetin OA
Jul 21, 2025, 19:30 ET Eisai to Present Four-Year Efficacy and Safety Data on Continuous Treatment with Lecanemab at The Alzheimer’s Association International Conference
10.1038/s41467-021-23507-z.Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706.U.S. Food and Drug Administration. 2023. FDA Converts Novel
More news about: Eisai Inc.
Jul 21, 2025, 08:45 ET Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
https://doi.org/10.1210/clinem/dgaf288.vi Bhargava A et al. Diab Tech Ther 2025; 27(5):366-375vii Thijs I, et al. J Diabetes Sci Technol. 2025 Mar 12:19322968251318373.
More news about: Medtronic plc
Jul 18, 2025, 10:51 ET New Mills, Fresh Capital, And High-Grade Drills Fuel Next Leg Of The Gold Bull Market
Gold Ltd. Technical information relating to Lake Victoria Gold Ltd. has been reviewed and approved by David Scott, Pr. Sci. Nat., a Qualified Person as defined by National Instrument 43-101. Mr. Scott is a registered member of the South African Council for Natural Scientific
More news about: Equity Insider
Jul 17, 2025, 10:44 ET Service Corporation International Announces Schedule For Second Quarter 2025 Earnings Release and Conference Call
/PRNewswire/ -- Service Corporation International (NYSE: SCI) announced it expects to issue a press release with financial results for the second quarter 2025 on Wednesday, July 30, 2025. A conference call will be hosted by SCI Management on Thursday, July
More news about: Service Corporation International